The Android app currently has more than half a million users. Medivo also owns several other chronic disease management apps, including those targeted at Crohn’s, hereditary angioedema and chronic myelogenous leukemia patients.
“We are extremely excited about adding the powerful OnTrack Diabetes app as a resource for patients to monitor their symptoms and to create reports that can be shared with their physician,” said Sundeep Bhan, CEO and cofounder of Medivo, in the news release. “This acquisition also fits with our growth strategy, enhances our consumer app portfolio and furthers our plans to develop new patient and physician engagement services.”
More Articles on mHealth:
Study: mHealth May Not Be As Effective in Promoting Physical Activity
The Hospital App Advantage: 5 Benefits of Going Mobile
Venture Capital Investment in mHealth Grows 35%
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.